Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick Sundram

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Internal Medicine Journal|March 5, 2026
Beyond beds and band-aids: A call for improved services across the whole dementia journeyDuncan Neilson, David Lie, Maree Todd, et al.
JMIR Mental Health|January 13, 2017
Tips and Traps: Lessons From Codesigning a Clinician E-Monitoring Tool for Computerized Cognitive Behavioral TherapyFrederick Sundram, Susan J Hawken, Karolina Stasiak, et al.
The New Zealand Medical Journal|September 14, 2023
Exploring the impact of e-learning modules and webinars on health professionals' understanding of the End of Life Choice Act 2019: a secondary analysis of Manatū Hauora - Ministry of Health workforce surveyAida Dehkhoda, Rosemary Frey, Melissa Carey, et al.
Psychiatry, Psychology, and Law : an Interdisciplinary Journal of the Australian and New Zealand Association of Psychiatry, Psychology and Law|June 1, 2026
Practitioners' attitudes and approaches to assessing comorbid depression among patients seeking assisted dying in New ZealandEric Zhou, Aida Dehkhoda, Susan Bull, et al.
The New Zealand Medical Journal|May 25, 2023
Health professionals' understanding and attitude towards the End of Life Choice Act 2019: a secondary analysis of Manatū Hauora - Ministry of Health workforce surveysAida Dehkhoda, Rosemary Frey, Melissa Carey, et al.
Trials|September 29, 2022
A randomized, double-blind, placebo-controlled, hybrid parallel-arm study of low-dose naltrexone as an adjunctive anti-inflammatory treatment for major depressive disorderJulia R Plank, Stephanie C Glover, Ben D Moloney, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 18, 2019
Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorderRebecca McMillan, Rachael Sumner, Anna Forsyth, et al.
Translational Psychiatry|April 15, 2024
LSD increases sleep duration the night after microdosingNathan Allen, Aron Jeremiah, Robin Murphy, et al.
Trials|February 12, 2020
A randomised, double-blind, active placebo-controlled, parallel groups, dose-response study of scopolamine hydrobromide (4-6 μg/kg) in patients with major depressive disorderJoseph C C Chen, Rachael L Sumner, Venkat Krishnamurthy Naga, et al.
Frontiers in Pharmacology|March 23, 2026
Low-dose naltrexone as an adjunctive treatment for major depressive disorder: findings from a randomized, double-blind, placebo-controlled hybrid parallel-arm studyBen D Moloney, Anna Forsyth, Rachael L Sumner, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Internal Medicine Journal|March 5, 2026
Beyond beds and band-aids: A call for improved services across the whole dementia journeyDuncan Neilson, David Lie, Maree Todd, et al.
JMIR Mental Health|January 13, 2017
Tips and Traps: Lessons From Codesigning a Clinician E-Monitoring Tool for Computerized Cognitive Behavioral TherapyFrederick Sundram, Susan J Hawken, Karolina Stasiak, et al.
The New Zealand Medical Journal|September 14, 2023
Exploring the impact of e-learning modules and webinars on health professionals' understanding of the End of Life Choice Act 2019: a secondary analysis of Manatū Hauora - Ministry of Health workforce surveyAida Dehkhoda, Rosemary Frey, Melissa Carey, et al.
Psychiatry, Psychology, and Law : an Interdisciplinary Journal of the Australian and New Zealand Association of Psychiatry, Psychology and Law|June 1, 2026
Practitioners' attitudes and approaches to assessing comorbid depression among patients seeking assisted dying in New ZealandEric Zhou, Aida Dehkhoda, Susan Bull, et al.
The New Zealand Medical Journal|May 25, 2023
Health professionals' understanding and attitude towards the End of Life Choice Act 2019: a secondary analysis of Manatū Hauora - Ministry of Health workforce surveysAida Dehkhoda, Rosemary Frey, Melissa Carey, et al.
Trials|September 29, 2022
A randomized, double-blind, placebo-controlled, hybrid parallel-arm study of low-dose naltrexone as an adjunctive anti-inflammatory treatment for major depressive disorderJulia R Plank, Stephanie C Glover, Ben D Moloney, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 18, 2019
Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorderRebecca McMillan, Rachael Sumner, Anna Forsyth, et al.
Translational Psychiatry|April 15, 2024
LSD increases sleep duration the night after microdosingNathan Allen, Aron Jeremiah, Robin Murphy, et al.
Trials|February 12, 2020
A randomised, double-blind, active placebo-controlled, parallel groups, dose-response study of scopolamine hydrobromide (4-6 μg/kg) in patients with major depressive disorderJoseph C C Chen, Rachael L Sumner, Venkat Krishnamurthy Naga, et al.
Frontiers in Pharmacology|March 23, 2026
Low-dose naltrexone as an adjunctive treatment for major depressive disorder: findings from a randomized, double-blind, placebo-controlled hybrid parallel-arm studyBen D Moloney, Anna Forsyth, Rachael L Sumner, et al.
Pageof 8